This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Centene's Contract Renewal to Aid Medicaid Members in Indiana
by Zacks Equity Research
Centene's (CNC) subsidiary MHS gets a contract renewal through which it will be able to efficiently serve its Medicaid members in Indiana.
Encompass Health Forms JV to Efficiently Serve South Carolina
by Zacks Equity Research
Encompass Health (EHC) and MUSC Health intend to offer improved healthcare services in South Carolina through a joint venture.
Zacks.com featured highlights include: BJ, ENSG, TGT, MTH and LOW
by Zacks Equity Research
Zacks.com featured highlights include: BJ, ENSG, TGT, MTH and LOW
Why Ensign (ENSG) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Ensign (ENSG).
5 Relative Price Strength Stocks You Will Regret Not Buying
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Ensign's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Ensign Group.
The Zacks Analyst Blog Highlights: Central Garden & Pet Company, Ensign Group, LogMeIn, Pool Corp. and Turning Point Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Central Garden & Pet Company, Ensign Group, LogMeIn, Pool Corp. and Turning Point Brands
5 Low-Risk Stocks to Buy for Election-Led Price Swings
by Tirthankar Chakraborty
As Wall Street is likely to grapple with election-led uncertainty in the near term, low-volatility stocks appear as a good bet at the moment.
Encompass Health's Buyout Spree on Track, PPE Costs High
by Zacks Equity Research
Encompass Health (EHC) continues to benefit from buyouts and cash generating abilities. However, increased PPE utilization is worrisome.
Ensign Group (ENSG) Continues to Gain From Buyout Binge
by Zacks Equity Research
Ensign Group's (ENSG) series of buyouts poise it well for growth by enhancing its capabilities, both financially and clinically.
Earnings Estimates Rising for Ensign Group (ENSG): Will It Gain?
by Zacks Equity Research
Ensign Group (ENSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q2 earnings results reflect better revenues from its Transitional and Skilled Services segment.
Ensign Group (ENSG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 36.84% and 2.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) to Report Q2 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Ensign Group (ENSG) closed the most recent trading day at $42.52, moving +1.6% from the previous trading session.
Ensign Group (ENSG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Ensign Group (ENSG) closed at $40.90, marking a +1.26% move from the previous day.
Ensign Group (ENSG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Ensign Group (ENSG) closed the most recent trading day at $42.20, moving -1.01% from the previous trading session.
Ensign Group (ENSG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Ensign Group (ENSG) closed at $41.99, marking a +1.18% move from the previous day.
Here's Why You Should Add Ensign Group to Your Portfolio
by Zacks Equity Research
Strategic initiatives and a healthy balance sheet make Ensign Group (ENSG) an attractive pick for investors.
Why Is Ensign Group (ENSG) Up 22.4% Since Last Earnings Report?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top ETFs & Stocks From Top-Ranked Sectors
by Sweta Killa
Investors could be well served by ETFs and stocks from sectors that house top-ranked industries.
Acadia Healthcare Ties Up for Improved Behavioral Services
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Covenant Health for offering improved mental health services in East Tennessee.
Humana Contract Renewal to Aid Medicaid Members in Kentucky
by Zacks Equity Research
Humana's (HUM) new agreement intends to efficiently serve Medicaid members of Kentucky, where it already boasts of a strong base.
Has The Ensign Group (ENSG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ENSG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed